Analysts’ Viewpoint on Fetal Bovine Serum Market Scenario
Increasing application in cell culture, drug discovery, vitro fertilization, and human & animal vaccine production is expected to drive the demand for fetal bovine serum (FBS) globally. Stakeholders in the fetal bovine serum market are driving their revenue by launching advanced cell culture products such as bioreactors, media, reagents, etc. Fetal bovine serum is made from bovine fetuses that are removed from pregnant cows during slaughter. There has been a decline in the production of fetal bovine serum in the past few years due to rising awareness about animal welfare across the globe. However, market players are focusing on innovative methods to increase the production of fetal bovine serum during the forecast period.
The fetal bovine serum market is moderately impacted by the COVID-19 pandemic due to lockdowns and closing of several research institutes & manufacturing units. However, there was a rise in demand for fetal bovine serum due to its increasing use in the production of antiviral drugs and vaccines during coronavirus. The growing use of fetal bovine serum in the preparation of vitro cell-culture is driving the demand amid the ongoing COVID-19 pandemic.
Market players and stakeholders have increased the on-demand production and supply of fetal bovine serum to grab incremental opportunities. Moreover, surging demand for effective vaccines for reducing the impact of the COVID-19 infection has created potential revenue opportunities for manufacturers. Academic and industrial researchers, and scientists use fetal bovine serum (FBS) in their cell culture media for biotechnology research, vaccine manufacturing & production, and cloning & animal diagnostics.
Fetal bovine serum is used as a raw material for research activities carried out in pharmaceutical organizations. The growing number of biotechnology, pharmaceutical, and diagnostics companies demand high fetal bovine serum for use. Furthermore, governments of various developing countries are supporting these research activities of pharmaceutical and biotechnology companies across the globe. The increasing awareness about the nutritional advantages of fetal bovine serum is fueling the growth of the fetal bovine serum market. Fetal bovine serum consists of various macromolecular factors, amino acids, sugars, lipids, and hormones that are necessary for cell growth.
The flourishing growth and development of biopharmaceutical companies is a significant factor contributing to the fetal bovine serum market growth. The use of fetal bovine serum as a growth supplement for in vitro culture system of eukaryotic cells is rising. The fetal bovine serum regulates cell membrane permeability and serves as a carrier for lipids, enzymes, and micronutrients into the cell. Technological advancement in biopharmaceuticals, innovative drug development process, and rising applications in cost-effective personalized medicine are some of the major factors driving the demand for biologics. Biomolecules are increasingly being used for the effective treatment of various diseases in healthcare companies. Biopharmaceutical companies are gaining attention due to the substantial investments and innovative manufacturing practices.
Since fetal bovine serum is an important component of cell culture media, its demand is increasing in North America. This nutrient-rich fluid is used in applications such as eukaryotic cell culture. North America is projected to account for the largest share of the global fetal bovine serum market during the forecast period. Expansion of biotechnology sector and increase in the number of pharmaceutical companies and research & development institutes in U.S. and Canada are driving the demand for fetal bovine serum for research and development of new drugs.
One of the key factor affecting the growth of the fetal bovine serum market is the ethical issues of using animal products. Awareness about animal safety and the number of animal activists in developing countries are rising. Fetal bovine serum is produced from pregnant cows during slaughter. This process is without giving a proper anesthesia to fetuses, causing intense pain and discomfort to them. Thus, several regions are started to use synthetic alternatives to FBS. In addition, rising complexities and technical issues associated with the use of FBS in cell culture are negatively affecting the market growth during the forecast period.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 842.73 Mn |
|
Market Forecast Value in 2031 |
US$ 1,647.47 Mn |
|
Growth Rate (CAGR) |
6.4% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Fetal Bovine Serum Market – Segmentation
TMR’s study on the global fetal bovine serum market includes information divided into three segments: application, end-user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global fetal bovine serum market is discussed in detail.
| Application |
|
| End-user |
|
| Region |
|
Fetal bovine serum market is expected to surpass the value of US$ 1.6 Bn by the end of 2031
Fetal bovine serum market to expand at a CAGR of 6.4% from 2021 to 2031
Fetal bovine serum market is driven by rise in demand for fetal bovine as a raw material by number of pharmaceutical & biotech companies for vaccines for human and animals.
North America accounted for the largest share of the global fetal bovine serum market, and the trend is projected to continue during the forecast period
Key players in the global fetal bovine serum market market include Merck ATCC, Bio-techne (Atlanta Biologicals), Captivate Bio, Danaher (Cytiva), HiMedia Laboratories
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fetal Bovine Serum Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fetal Bovine Serum Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. Pipeline Analysis
5.3. Regulatory scenario, by Region/Globally
5.4. Covid-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Fetal Bovine Serum Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017-2031
6.3.1. Drug Discovery
6.3.2. Cell Media Culture
6.3.3. In Vitro Fertilization
6.3.4. Human & Animal Vaccine Production
6.3.5. Diagnostics
6.3.6. Others
6.4. Market Attractiveness Analysis, by Application
7. Global Fetal Bovine Serum Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Research & Academic Institutes
7.3.2. Industry (pharma, biotech, etc.)
7.3.3. Healthcare Facilities
7.4. Market Attractiveness Analysis, by End-user
8. Global Fetal Bovine Serum Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Fetal Bovine Serum Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017-2031
9.2.1. Drug Discovery
9.2.2. Cell Media Culture
9.2.3. In Vitro Fertilization
9.2.4. Human & Animal Vaccine Production
9.2.5. Diagnostics
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Research & Academic Institutes
9.3.2. Industry (pharma, biotech, etc.)
9.3.3. Healthcare Facilities
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Fetal Bovine Serum Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017-2031
10.2.1. Drug Discovery
10.2.2. Cell Media Culture
10.2.3. In Vitro Fertilization
10.2.4. Human & Animal Vaccine Production
10.2.5. Diagnostics
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Research & Academic Institutes
10.3.2. Industry (pharma, biotech, etc.)
10.3.3. Healthcare Facilities
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Fetal Bovine Serum Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017-2031
11.2.1. Drug Discovery
11.2.2. Cell Media Culture
11.2.3. In Vitro Fertilization
11.2.4. Human & Animal Vaccine Production
11.2.5. Diagnostics
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Research & Academic Institutes
11.3.2. Industry (pharma, biotech, etc.)
11.3.3. Healthcare Facilities
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Fetal Bovine Serum Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017-2031
12.2.1. Drug Discovery
12.2.2. Cell Media Culture
12.2.3. In Vitro Fertilization
12.2.4. Human & Animal Vaccine Production
12.2.5. Diagnostics
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Research & Academic Institutes
12.3.2. Industry (pharma, biotech, etc.)
12.3.3. Healthcare Facilities
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Fetal Bovine Serum Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017-2031
13.2.1. Drug Discovery
13.2.2. Cell Media Culture
13.2.3. In Vitro Fertilization
13.2.4. Human & Animal Vaccine Production
13.2.5. Diagnostics
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Research & Academic Institutes
13.3.2. Industry (pharma, biotech, etc.)
13.3.3. Healthcare Facilities
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Business Strategies
14.3.1.5. Recent Developments
14.3.2. ATCC
14.3.2.1. Company Overview
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. Business Strategies
14.3.2.5. Recent Developments
14.3.3. Bio-techne (Atlanta Biologicals, Inc.)
14.3.3.1. Company Overview
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. Business Strategies
14.3.3.5. Recent Developments
14.3.4. Captivate Bio
14.3.4.1. Company Overview
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. Business Strategies
14.3.4.5. Recent Developments
14.3.5. Danaher (Cytiva)
14.3.5.1. Company Overview
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. Business Strategies
14.3.5.5. Recent Developments
14.3.6. HiMedia Laboratories
14.3.6.1. Company Overview
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. Business Strategies
14.3.6.5. Recent Developments
14.3.7. Merck KGaA
14.3.7.1. Company Overview
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. Business Strategies
14.3.7.5. Recent Developments
14.3.8. Pan Biotech GmbH
14.3.8.1. Company Overview
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. Business Strategies
14.3.8.5. Recent Developments
14.3.9. Rocky Mountain Biologicals
14.3.9.1. Company Overview
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. Business Strategies
14.3.9.5. Recent Developments
14.3.10. TCS Biosciences Ltd.
14.3.10.1. Company Overview
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. Business Strategies
14.3.10.5. Recent Developments
14.3.11. Thermo Fisher Scientific Inc.
14.3.11.1. Company Overview
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. Business Strategies
14.3.11.5. Recent Developments
14.3.12. Zen-Bio, Inc.
14.3.12.1. Company Overview
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. Business Strategies
14.3.12.5. Recent Developments
List of Tables
Table 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 02: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 06: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 09: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 02: Global Fetal Bovine Serum Market Value Share (%), by Region, 2020
Figure 03: Global Fetal Bovine Serum Market Value Share (%), by Application, 2020
Figure 04: Global Fetal Bovine Serum Market Value Share (%), by End-user, 2020
Figure 05: Global Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 06: Global Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 07: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Drug Discovery, 2017–2031
Figure 08: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Cell Media Culture, 2017–2031
Figure 09: Global Fetal Bovine Serum Market Revenue (US$ Mn), by In Vitro Fertilization, 2017–2031
Figure 10: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Human & Animal Vaccine Production, 2017–2031
Figure 11: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Diagnostics, 2017–2031
Figure 12: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Others, 2017–2031
Figure 13: Global Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
Figure 14: Global Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031
Figure 15: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Research & Academic Institutes, 2017–2031
Figure 16: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Industry, 2017–2031
Figure 17: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Healthcare Facilities, 2017–2031
Figure 18: Global Fetal Bovine Serum Market Value Share Analysis
Figure 19: Global Fetal Bovine Serum Market Attractiveness Analysis, by Region, 2021–2031
Figure 20: North America Fetal Bovine Serum Market Value Share Analysis, by Country, 2020 and 2031
Figure 21: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 22: North America Fetal Bovine Serum Market Attractiveness Analysis, by Country, 2021–2031
Figure 23: North America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 24: North America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 25: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 20201–2031
Figure 26: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 27: Europe Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 28: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 29: Europe Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
Figure 30: Europe Fetal Bovine Serum Market Attractiveness Index Analysis, by End-user, 2021–2031
Figure 31: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 32: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 33: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 34: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 35: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 36: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
Figure 37: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031
Figure 38: Latin America Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 39: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 41: Latin America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 42: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 43: Latin America Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
Figure 44: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031
Figure 45: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 46: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 47: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 48: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
Figure 49: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031
Figure 50: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
Figure 51: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Fetal Bovine Serum Market
